Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina [Phase 4]
Phase 4 clinical trial evaluating ranolazine in individuals with chronic stable angina completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Effect of Linagliptin on TRL Metabolism [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating linagliptin's effect on triglyceride-rich lipoprotein metabolism in …
-
FDA approval · 2014-11-03FDA Approved: GLIMEPIRIDE — Supplemental Application (Accord Healthcare Inc)
FDA approved a supplemental application for glimepiride filed by Accord Healthcare Inc.
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of LX4211 in combination with metformin in adults with Type 2 Diabetes Mellitus wh…
-
FDA approval · 2014-10-30FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 study of LY2189265 in Japanese participants with Type 2 Diabetes Mellitus has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment [Phase 3]
Phase 3 trial assessing liraglutide as add-on therapy to existing diabetes medication in people with type 2 diabetes and moderate renal impa…
-
FDA approval · 2014-10-29FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Original Application (Prasco Laboratories)
The FDA approved a fixed-dose combination tablet of dapagliflozin and metformin hydrochloride from Prasco Laboratories for adults with type …
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes
A completed observational study evaluating the safety of Levemir (insulin detemir) in patients with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: E-health Care Process Support for Diabetes Type II Patients [NA]
A completed clinical trial evaluating e-health care process support for patients with Type 2 diabetes mellitus; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluated liraglutide added to basal insulin (with or without metformin) in people with Type 2 diabetes. The study completed…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes [Phase 2]
Phase 2 clinical trial assessing intranasal insulin to enhance cerebral vasoreactivity and cognition in adults with type 2 diabetes; trial c…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Effects of Pinitol on Hidrocarbonated Metabolism Parameters in Diabetic, Impaired and Normal Fasting Glucose Subjects [NA]
This completed clinical trial evaluated the effects of pinitol on glucose metabolism parameters in subjects with Type 2 diabetes mellitus, i…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Pioglitazone and Losartan Provides Additional Renoprotection [NA]
A completed clinical trial evaluating pioglitazone plus losartan suggests additional renoprotective effects in patients with type 2 diabetes…
-
CLINICAL_TRIALS withdrawal · 2014-10-27Clinical Trial Update: Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing empagliflozin to sitagliptin in patients with Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 2]
Phase 2 study assessing safety, pharmacokinetics, and pharmacodynamics of multiple oral bedtime doses of ORMD-0801 in adults with Type 2 dia…
-
CLINICAL_TRIALS research · 2014-10-23Clinical Trial Update: Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans [Phase 1]
Phase 1 study completed examining how genetic variants in MATE1 and OCT3 alter metformin pharmacodynamics in African Americans, including he…
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Relationship Between HbA1c, Fasting Plasma Glucose, Post-prandial Glucose and Other Measures of Glycemic Control
This completed study examined the relationships between HbA1c, fasting plasma glucose, post-prandial glucose and other measures of glycemic …
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266) [Phase 3]
A Phase 3 clinical trial of MK-0431D (fixed-dose sitagliptin/simvastatin) for type 2 diabetes patients on metformin was terminated; results …
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe [Phase 1]
Phase 1 trial comparing dulaglutide administration via auto-injector versus manual syringe; the study was completed and results posted.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake [Phase 2]
Phase 2 study evaluating the safety and efficacy of Technosphere Insulin Inhalation Powder at an optimal dose with varied carbohydrate intak…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Rectal Short Chain Fatty Acids Combinations and Substrate and Energy Metabolism [NA]
A completed clinical trial investigating rectal short-chain fatty acids combinations and their effects on substrate and energy metabolism in…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler [Phase 3]
A Phase 3 trial evaluating Technosphere Inhalation Insulin (TI) using the Gen2 inhaler in Type 2 diabetes was terminated; results were poste…
-
CLINICAL_TRIALS research · 2014-10-21Clinical Trial Update: Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects [Phase 1]
This Phase 1 trial assesses how food affects the pharmacokinetics of oral semaglutide in healthy subjects.
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 study evaluating dulaglutide in Japanese participants with Type 2 Diabetes Mellitus completed; results were posted in 2014.